Cargando…
Eligibility for Posthospitalization Venous Thromboembolism Prophylaxis in Hospitalized Patients With COVID‐19: A Retrospective Cohort Study
BACKGROUND: A recent randomized trial, the MICHELLE trial, demonstrated improved posthospital outcomes with a 35‐day course of prophylactic rivaroxaban for patients hospitalized with COVID‐19 at high risk of venous thromboembolism. We explored how often these findings may apply to an unselected clin...
Autores principales: | Vaughn, Valerie M., Ratz, David, McLaughlin, Elizabeth S., Horowitz, Jennifer K., Flanders, Scott A., Middleton, Elizabeth A., Grant, Paul J., Kaatz, Scott, Barnes, Geoffrey D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673710/ https://www.ncbi.nlm.nih.gov/pubmed/36073649 http://dx.doi.org/10.1161/JAHA.122.025914 |
Ejemplares similares
-
Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19
por: Vaughn, Valerie M., et al.
Publicado: (2021) -
Three-day antibiotic duration in patients with pneumonia: A sixty-eight–hospital cohort
por: Vaughn, Valerie, et al.
Publicado: (2023) -
Risk Factors and outcomes associated with inappropriate empiric broad-spectrum antibiotic use in hospitalized patients with community-acquired pneumonia
por: Gandhi, Tejal, et al.
Publicado: (2023) -
Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status
por: Roubinian, Nareg H., et al.
Publicado: (2022) -
Identifying the relationship between hospital rurality and antibiotic overuse
por: Hardin, Hannah, et al.
Publicado: (2023)